Upgrade to SI Premium - Free Trial

CVS Health (CVS) Q3 Solid But Guidance Well Behind - Leerink

November 8, 2016 8:42 AM
Leerink Partners analyst David Larsen weighed in on CVS Health (NYSE: CVS) following solid Q3 results but disappointing guidance which ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View

Next Articles